Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
NCT04747496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2025-01-09
Summary
The safety of edoxaban treatment will be examined using real-world clinical evidence from adult patients with non-valvular atrial fibrillation (NVAF) indications in routine clinical practice.
Conditions
- Non-valvular Atrial Fibrillation
Interventions
- DRUG
-
Edoxaban
This is a non-interventional, observational study.
Sponsors & Collaborators
-
Daiichi Sankyo Co., Ltd.
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
Global Clinical Leader · Daiichi Sankyo
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-26
- Primary Completion
- 2024-11-27
- Completion
- 2024-11-27
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
NCT06108414 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Dapagliflozin in Preventing Atrial Fibrillation Recurrence After Catheter Ablation
NCT06740786 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF
NCT03554837 ·Status: UNKNOWN
-
Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment
NCT01857622 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
NCT03087487 ·Status: COMPLETED
-
DOAC in Chinese Patients With Atrial Fibrillation
NCT05378035 ·Status: RECRUITING
-
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
NCT04792190 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
NCT02964949 ·Status: COMPLETED ·Phase: NA
-
The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)
NCT00343499 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation
NCT03570047 ·Status: COMPLETED
-
Effect of Dapagliflozin on VT in Patients With Heart Failure.
NCT05550441 ·Status: UNKNOWN ·Phase: PHASE4
-
The Modified "Pills-in-the-Pocket" Strategy
NCT06657404 ·Status: RECRUITING ·Phase: NA
-
A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure
NCT00303498 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT03508271 ·Status: COMPLETED
-
Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
NCT04195997 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Safety and Effectiveness on Oral Anticoagulants
NCT03765242 ·Status: COMPLETED
-
A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
NCT00174785 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
NCT05659264 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation
NCT06280768 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
An Exploratory stuDy of effectIveneSs and Safety of rivarOxaban in Patients With Left VEntricular Thrombus (R-DISSOLVE)
NCT04970381 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
NCT03470545 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
NCT03351738 ·Status: COMPLETED ·Phase: PHASE2
-
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
NCT04128878 ·Status: COMPLETED
-
Efficacy and Safety Study of F373280
NCT01831856 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
NCT03855826 ·Status: UNKNOWN ·Phase: PHASE4